Status:
COMPLETED
Zyvox (Linezolid) Special Investigation For Vancomycin-Resistant Enterococci (VRE)
Lead Sponsor:
Pfizer
Conditions:
Vancomycin Resistance Enterococcus Faecium
Eligibility:
All Genders
Brief Summary
To collect the efficacy and safety information in subjects who have been treated with Zyvox (linezolid) for vancomycin resistance Enterococcus faecium infection for their appropriate use in daily prac...
Eligibility Criteria
Inclusion
- Subject to whom Zyvox (linezolid) was administered.
- Infected subject with Vancomycin resistance Enterococcus faecium.
Exclusion
- Infected subject with MRSA and other organism.
Key Trial Info
Start Date :
May 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT01224626
Start Date
May 1 2006
End Date
April 1 2011
Last Update
July 2 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.